• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者的高血压

Hypertension in patients with diabetes mellitus.

作者信息

Skyler J S, Marks J B, Schneiderman N

机构信息

Department of Medicine, University of Miami, Florida, USA.

出版信息

Am J Hypertens. 1995 Dec;8(12 Pt 2):100s-105s. doi: 10.1016/0895-7061(95)00307-x.

DOI:10.1016/0895-7061(95)00307-x
PMID:8845091
Abstract

Diabetes mellitus and hypertension each confer increased cardiovascular risk. That risk is much greater when the diseases coexist and is further magnified by their frequent association with dyslipidemia and central obesity. Insulin resistance appears to be an important common component to these four entities, whether or not the relationship is truly cause and effect. Increased renal tubule absorption of sodium and increased sympathetic nervous system stimulation from insulin have been said to be the mechanisms by which elevated levels of insulin cause hypertension. However, animal experiments suggest that these are short-term effects only and that long-term insulin may actually increase peripheral blood flow and reduce blood pressure. Experiments in humans suggest that the insulin resistant state in obese patients and type II diabetics is associated with a decrease of the usual vasodilatory effect of insulin. Antihypertensive drugs have differing effects on insulin resistance. Angiotensin converting enzyme inhibitors, alpha-adrenergic blockers, and dihydropyridines appear to improve insulin sensitivity. Other calcium channel blockers appear to be neutral, as is furosemide. Thiazide diuretics, spironolactone, and beta-adrenergic blockers impair insulin sensitivity. The drugs that increase insulin sensitivity also tend to improve dyslipidemia or remain lipid neutral. In contrast, those drugs that tend to impair insulin sensitivity also tend to worsen dyslipidemia.

摘要

糖尿病和高血压各自都会增加心血管疾病风险。当这两种疾病同时存在时,这种风险会大得多,并且由于它们经常与血脂异常和中心性肥胖相关联,风险会进一步放大。胰岛素抵抗似乎是这四种情况的一个重要共同因素,无论这种关系是否真的是因果关系。肾小管对钠的重吸收增加以及胰岛素引起的交感神经系统刺激增加被认为是胰岛素水平升高导致高血压的机制。然而,动物实验表明这些只是短期效应,长期胰岛素实际上可能会增加外周血流量并降低血压。人体实验表明,肥胖患者和II型糖尿病患者的胰岛素抵抗状态与胰岛素通常的血管舒张作用减弱有关。抗高血压药物对胰岛素抵抗有不同的影响。血管紧张素转换酶抑制剂、α-肾上腺素能阻滞剂和二氢吡啶类药物似乎能改善胰岛素敏感性。其他钙通道阻滞剂似乎是中性的,速尿也是如此。噻嗪类利尿剂、螺内酯和β-肾上腺素能阻滞剂会损害胰岛素敏感性。增加胰岛素敏感性的药物也往往会改善血脂异常或保持血脂中性。相比之下,那些往往会损害胰岛素敏感性的药物也往往会使血脂异常恶化。

相似文献

1
Hypertension in patients with diabetes mellitus.糖尿病患者的高血压
Am J Hypertens. 1995 Dec;8(12 Pt 2):100s-105s. doi: 10.1016/0895-7061(95)00307-x.
2
Treatment of obesity hypertension and diabetes syndrome.肥胖、高血压和糖尿病综合征的治疗。
Hypertension. 2001 Sep;38(3 Pt 2):705-8. doi: 10.1161/01.hyp.38.3.705.
3
Carbohydrate metabolism in hypertension: influence of treatment.高血压中的碳水化合物代谢:治疗的影响
J Cardiovasc Pharmacol. 1993;22 Suppl 6:S87-97.
4
[Insulin resistance and arterial hypertension].[胰岛素抵抗与动脉高血压]
Herz. 1995 Feb;20(1):16-32.
5
Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.通过抑制肾素-血管紧张素系统预防2型糖尿病
Drugs. 2004;64(22):2537-65. doi: 10.2165/00003495-200464220-00004.
6
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.抗高血压药物对胰岛素、葡萄糖及脂质代谢的影响。
Diabetes Care. 1991 Mar;14(3):203-9. doi: 10.2337/diacare.14.3.203.
7
Is hypertension an insulin-resistant state? Metabolic changes associated with hypertension and antihypertensive therapy.
Am Heart J. 1991 Sep;122(3 Pt 2):932-5. doi: 10.1016/0002-8703(91)90814-x.
8
Metabolic considerations in hypertension.高血压中的代谢因素
Am J Hypertens. 1990 Dec;3(12 Pt 2):355S-365S.
9
Diabetes mellitus and hypertension.糖尿病和高血压。
Am J Kidney Dis. 1990 Oct;16(4 Suppl 1):20-9.
10
Metabolic considerations in the approach to diabetic hypertensive patients.糖尿病高血压患者治疗中的代谢考量
Am J Med. 1989 Dec 8;87(6A):34S-38S. doi: 10.1016/0002-9343(89)90493-2.

引用本文的文献

1
Isolated systolic hypertension and its associated risk factors in Iranian middle age and older population: a population-based study.伊朗中老年人群孤立性收缩期高血压及其相关危险因素:一项基于人群的研究。
BMC Cardiovasc Disord. 2022 Sep 27;22(1):425. doi: 10.1186/s12872-022-02856-7.
2
Molecular mechanisms linking stress and insulin resistance.连接压力与胰岛素抵抗的分子机制。
EXCLI J. 2022 Jan 24;21:317-334. doi: 10.17179/excli2021-4382. eCollection 2022.
3
Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?
交感神经系统是否参与代谢综合征的病理生理过程?
Front Physiol. 2015 Aug 25;6:234. doi: 10.3389/fphys.2015.00234. eCollection 2015.
4
Perturbed autonomic nervous system function in metabolic syndrome.代谢综合征中自主神经系统功能紊乱
Neuromolecular Med. 2008;10(3):169-78. doi: 10.1007/s12017-008-8022-5. Epub 2008 Jan 26.
5
Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.基于1999年加拿大高血压管理建议的临床问题解决
CMAJ. 1999;161 Suppl 12(12):S18-22.
6
1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.1999年加拿大高血压管理指南。1999年加拿大高血压管理指南制定工作组。
CMAJ. 1999;161 Suppl 12(12):S1-17.